For example, in hepatocellular carcinoma in which a high expression level of CXCR2 ligand was observed, Liu et al. confirmed that using CXCR2 CAR T cells could enhance in vivo trafficking and tumor cytotoxicity [157]. The gene discussed is CXCR2; the disease is neoplasm.